Cocoa (CC)

La vendita allo scoperto per Chemours dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Chemours. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Chemours (NYSE:CC) Azioni, Report sulle vendite allo scoperto

CHEMOURS CO/THE

Chemours

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

News

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

TROX

Analisi di tre titoli del settore materiali con dividendi eccezionali, valutati dagli analisti di Wall Street per il potenziale di crescita.

Azioni con dividendi superiori al 5%: il parere degli esperti di Wall Street

Ecco le tre azioni nel settore dei materiali che offrono alti rendimenti e sono raccomandate dai migliori esperti finanziari di Wall Street.

Titoli a dividendo: le 3 azioni consigliate dagli analisti di Wall Street

KALU

Le azioni di Chemours, Tronox e Kaiser Aluminum offrono interessanti rendimenti per gli investitori nel settore dei materiali nel 2025.

3 azioni ad alto dividendo nel settore dei materiali per il 2025

The Chemours Co

COASTAL CAPITAL ACQSTN CP by Coastal Capital Acquisition Corp.

Coastal Capital Acquisition Corp

Crescent Capital BDC, Inc. - Common Stock

Crescent Capital BDC Inc

COLONIAL COAL INTL ORD by Colonial Coal International Corp

Colonial Coal International Corp

CARLOS CASADO SA S/ADR B by Carlos Casado S.A.

Carlos Casado SA

Coastal Financial Corporation - Common Stock

Coastal Financial Corp

CHINO COMML BANCORP (CA) by Chino Commercial Bancorp

Chino Commercial Bancorp

Capital City Bank Group Inc

CHINA CBM GROUP CO LTD by CHINA CBM GROUP CO LTD.

C4 Therapeutics Inc

CARLYLE COMMODITIES CORP by CARLYLE COMMODITIES CORP.

Carlyle Commodities Corp

CITY CHIC COLLECTIVE LTD by City Chic Collective Ltd.

City Chic Collective Ltd

CHINA CABLE & COMMUNS INC by China Cable & Communication, Inc.

China Cable and Communication Inc

CANCOM SE

Crona Corp

CCC Intelligent Solutions Holdings Inc. - Common Stock

CCC Intelligent Solutions Holdings Inc

Calamos Dynamic Convertible & Income Fund - Closed End Fund

Calamos Dynamic Convertible and Income Fund

Concordium - United States Dollar

CCL INDUS INC B CDA by CCL Industries Inc.

CCL Industries Inc

CAN DO COMPANY LTD TOKYO by Can Do Co., Ltd.

Can Do Co Ltd

Capital Clean Energy Carriers Corp. - Common Share

Capital Clean Energy Carriers Corp

CASCADERO COPPER CORP by Cascadero Copper Corp.

Cascadero Copper Corp

Calamos ETF Trust Calamos CEF Income & Arbitrage ETF

CARCLO ENGR PLC ORD by Carclo Engineering Plc

Carclo PLC

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International Inc

Coca-Cola Europacific Partners plc - Ordinary Shares

Coca-Cola Europacific Partners PLC

Cal-Comp Electronics (Thailand) PCL Units Non-Voting Depository Receipt

Cal-Comp Electronics (Thailand) PCL

Chase Corp. Com.

CCSB Financial Corp Com

CCF Holdings LLC

MUNCY COLUMBIA FNCL by Muncy Columbia Financial Corporation

Muncy Columbia Financial Corp

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group Inc

CHINA CINDA ASSET MGMT CO by China Cinda Asset Management Co Ltd

China Cinda Asset Management Co Ltd

CREDIT CORP GROUP LTD by Credit Corp Group Ltd.

Credit Corp Group Ltd

China CGame Inc

C&C Group PLC

CHINA CLEAN ENERGY INC by China Clean Energy, Inc.

China Clean Energy Inc

COCA COLA HBC LTD ORD by COCA COLA HBC LTD

Coca-Cola HBC AG

COCA COLA HBC UNSP/ADR by Coca-Cola HBC AG

CAMBRIDGE CAP HLDGS INC by Cambridge Capital Holdings, Inc.

Cambridge Capital Holdings Inc

CENTRAL CHINA MGMT CO LTD by CENTRAL CHINA MGMT CO LTD.

Central China Management Co Ltd

CENTRAL CHNA NEW LIFE LTD by CENTRAL CHINA NEW LIFE LTD.

The Cannabist Company Holdings Inc

CAREER COLLEGE HLDG CO by Career College Holding Co., Inc .

Career College Holding Co Inc

Crown Castle Inc

Carlyle Credit Income Fund 8.75% Series A Preferred Shares due 2028

Carlyle Credit Income Fund

Carlyle Credit Income Fund Shares of Beneficial Interest

Cohen Circle Acquisition Corp. I - Class A Ordinary Shares

Cohen Circle Acquisition Corp I

Cohen Circle Acquisition Corp. I - Warrant

Churchill Capital Corp IX - Ordinary Shares

Churchill Capital Corp IX

Cameco Corp

Crown Holdings Inc

Clicks Group Ltd

Carnival Corp

CareCloud Inc

CareCloud, Inc. - 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock

CareCloud Inc 11 % Cum Red Perp Pfd Registered Shs Series -A-

CC LAND HOLDINGS LTD ORD by CC Land Holdings Ltd.

C C Land Holdings Ltd

CCL INDUS INC CL (A) ORD by CCL Industries Inc.

CSI Compressco LP Com Unit

Chori Co Ltd

CABLECLIX (USA) INC by CableClix (USA), Inc.

CableClix (USA) Inc

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services Holdings Ltd

EA Series Trust CCM Global Equity ETF

CMC MARKETS PLC LON ORD by CMC Markets PLC London

CMC Markets PLC

CALLAHAN CONSOL MINES by Callahan Consolidated Mines, Inc.

COASTAL CAROLINA BANC by Coastal Carolina Bancshares Inc

Coastal Carolina Bancshares Inc

Kaizen Discovery Inc

CNB Financial Corp

CNB Financial Corporation - Depositary shares, each representing a 1/40th ownership interest in a share of 7.125% Series A Fixed- Rate Non-Cumulative Perpetual Preferred Stock

COCONALA INC by COCONALA INC.

ALPS/CoreCommodity Natural Resources ETF

Concentric AB

Clear Channel Outdoor Holdings, Inc. Common Stock

Clear Channel Outdoor Holdings Inc

CENTURY COBALT CORP by Century Cobalt Corp.

Century Cobalt Corp

Capcom Co Ltd

CHINA ST CONSTR INTL HLDG by China State Construction International Holdings, Ltd.

China State Construction International Holdings Ltd

Cogent Communications Holdings, Inc. - Common Stock

Cogent Communications Holdings Inc

COCA COLA BOTTLERS JAPAN by Coca-Cola Bottlers Japan Inc.

Coca-Cola Bottlers Japan Holdings Inc

COCA COLA BOTTLRS JPN ADR by Coca-Cola Bottlers Japan Inc.

Core Assets Corp

CANADIAN COPPER INC by CANADIAN COPPER INC.

Core Alternative ETF

CANACCORD GENUITY GRP INC by Canaccord Genuity Group, Inc.

Canaccord Genuity Group Inc

CHINA COAL ENGY CO H SHS by China Coal Energy Co., Ltd.

China Coal Energy Co Ltd

CHINA COAL ENGY CO ADR by China Coal Energy Co., Ltd.

SYN PROP E TECH GDR 144A by SYN Prop e Tech SA

SYN Prop E Tech SA

CAPITAL & COUNTIES ORD by Capital & Counties Properties PLC, London

Shaftesbury Capital PLC

SATO TECHNOLOGIES CORP by SATO TECHNOLOGIES CORP

SATO Technologies Corp

CoreCard Corp

CONCORDIA FINCL GRP LTD by Concordia Financial Group, Ltd.

Concordia Financial Group Ltd

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare Inc

GREEN RIVER GOLD CORP by Green River Gold Corp.

Green River Gold Corp

iShares U.S. ETF Trust iShares Commodity Curve Carry Strategy ETF

Century Communities Inc

Wedbush analyst&nbsp;Dan Ives&nbsp;has voiced criticism of President Donald Trump&#8216;s tariff calculations, comparing them to a high school economics project.
What Happened: On Thursday, Ives, through a post on X, expressed his views on the tariff numbers presented by the Trump administration. He suggested that the calculations, which are based on each country&#8217;s trade surplus divided by their total imports with the U.S., are overly simplistic and fail to consider complex economic factors.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The tariff numbers are a convoluted set of calculations that appear to be taking each nation&#39;s trade surplus by their total imports with the US. If a 9th grader in high school presented this tariff chart to a teacher in a basic econ class the teacher would laugh and say sit down
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1907736465318031419?ref_src=twsrc%5Etfw">April 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
These calculations were defended by Treasury Secretary&nbsp;Scott Bessent&nbsp;in March as a means to balance trade deficits. However, Ives and other critics argue that the approach ignores important elements such as&nbsp;exchange rates and global trade&nbsp;dynamics.
Why It Matters: While there is a lot of speculation over the reciprocal tariff calculation, the U.S. Trade Representative&#8217;s Office (U.S.T.R.) outlined its strategy and the calculation formula on its website. The U.S.T.R. also provided the methodology to calculate the elasticity or responsiveness of imports to changes in import prices.
Trinh Nguyen, senior economist of emerging Asia at Natixis, told CNBC, "The formula is about trade imbalances with the U.S. rather than reciprocal tariffs in the sense of tariff level or non-tariff level distortions. This makes it very difficult for Asian countries, particularly the poorer Asian countries, to meet US demand to reduce tariffs in the short term, as the benchmark is buying more American goods than they export to the U.S." 
Meanwhile, James Surowiecki, a writer for The Atlantic and Fast Company, called the reciprocal tariff methodology &#8220;dumb and deceptive&#8221; in a post on X.
On the other hand, a few analysts opined that the methodology of the Trump administration could give it more room for trade agreements with other countries. Rob Subbaraman, head of global macro research at Nomura, told the publication, &#8220;&#8230;the opaqueness surrounding the tariff numbers may add some flexibility in making deals, but it could come at a cost to U.S. credibility."
The tariff policy, as outlined by the USTR, has sparked a debate among experts. Ives&#8217; analogy of the tariff chart being akin to a 9th grader&#8217;s economics project reflects this broader skepticism.
<ul>
<li>Read Next:&nbsp;<a href="https://benzinga.com/25/04/44622346/trumps-reciprocal-tariff-math-a-masterclass-in-economic-absurdity" target="_blank" rel="noreferrer noopener">Trump&#8217;s &#8216;Reciprocal Tariff&#8217; Math: A Masterclass In Economic Absurdity &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

'Teacher Would Laugh And Say Sit Down:' Top Analyst Compares Trump's Reciprocal Tariff Calculations To A 9th Grader's Economics Project

Needham analyst David Saxon reiterates RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) with a Buy and maintains $43 price target.

Reiteration

RXST

Needham Reiterates Buy on RxSight, Maintains $43 Price Target

Needham analyst Quinn Bolton reiterates Penguin Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) with a Buy and maintains $27 price target.

Penguin Solutions, Inc. - Ordinary Shares

PENG

Needham Reiterates Buy on Penguin Solutions, Maintains $27 Price Target

RH: -27% &#x7C; <a href="https://www.benzinga.com//node/44615129">RH shares are trading lower after the company reported Q4 financial results and missed its adjusted EPS and revenue estimates.</a>
&nbsp;
AAPL: -7% &#x7C; <a href="https://www.benzinga.com//node/44624755">Tigress Financial Maintains Strong Buy on Apple, Raises Price Target to $300</a>

Movers

AAPL

Market-Moving News for April 3rd

SRS and SBRT are non-surgical procedures that deliver precisely targeted doses of radiotherapy, typically in one to five treatment sessions, with the goal of ablating (destroying) the tumor or lesion. To achieve the accuracy and precision required, the CyberKnife System uses image guidance during treatment, and leverages potentially 1,000 different beam angles targeting the tumor as well as Synchrony&#xAE; adaptive delivery, which adjusts the aim of the beam in real time to correct for tumor or patient motion.
"The studies presented at this year's Radiosurgery Society meeting underscore both the long-term efficacy and expanding applications of the CyberKnife System. Whether treating benign tumors like vestibular schwannoma or managing complex conditions such as spinal metastases and trigeminal neuralgia, the common thread is the need for precise, highly targeted radiation delivery — a hallmark of the CyberKnife System. These new data not only reinforce its value in central nervous system treatments but also add to the growing body of evidence supporting its role in improving both the quality and longevity of patients' lives," said Seth Blacksburg, M.D., MBA, Chief Medical Officer at Accuray.
RSS CyberKnife System Study Highlights: Advancing and Expanding Patient Care
25-Year Data Supports the Use of the CyberKnife System to Treat Vestibular Schwannoma (VS)
<ul>
<li>25-year data were reported for patients in a single institution study retrospectively evaluating SRS for the treatment of VS (also known as acoustic neuroma) using the CyberKnife System. A non-cancerous, usually slow-growing brain tumor, VS can cause hearing loss, ringing in the ear, and dizziness or loss of balance. The study demonstrated treatment with the system provides sustained local tumor control and long-term efficacy. At 25 years, the local control rate was 89.3 percent and overall survival was 97.1 percent 2.</li>
</ul>
Clinical Innovation Facilitates Treatment of Challenging Condition Using the CyberKnife System
<ul>
<li>A study evaluated the safety and efficacy of donut-shaped circumferential stereotactic body radiation therapy (SBRT) delivered using the CyberKnife System for the treatment of spinal metastases. This treatment technique is designed to target the spinal column while avoiding the spinal cord. High doses of radiation delivered to the spinal cord can result in serious complications, such as radiation myelopathy, causing injury or paralysis. Study investigators concluded, "Donut-shaped circumferential CyberKnife SBRT is a safe and effective treatment for spinal metastases, achieving high local tumor control with minimal radiation-induced complications, including myelopathy&nbsp;3."</li>
</ul>
CyberKnife System Expands Treatment Options for Patients with Painful Neurological Conditions Trigeminal neuralgia and occipital condyle metastasis are rare conditions often causing excruciating pain that may impact all aspects of patients' daily life.
<ul>
<li>A study of elderly patients (aged 80 to 100 years) with trigeminal neuralgia found that radiosurgery delivered using the CyberKnife System provides excellent outcomes. Pain improved or disappeared in 90 percent of those evaluated and only three percent developed paresthesia – a sensation of tingling, "pins and needles" or numbness – considered bothersome. Data indicate radiosurgery provides an option for a patient population that may have limited choices because health issues preclude surgery or they are unresponsive to medication4.</li>
<li>An evaluation of SRS for occipital condyle metastasis (OCM) using the CyberKnife System found the treatment offers significant pain relief, excellent local control rates and improvement in neurological symptoms. A 93.8 percent local tumor control rate was achieved over three years. Of patients who reported symptoms, 87.5 percent experienced pain relief. Study authors concluded, "This non-invasive therapy provides a valuable alternative to surgery, potentially enhancing the quality of life for patients with limited treatment options due to this challenging condition5."</li>
</ul>

Health Care

General

ARAY

Accuray Announced That New Data On The Clinical Use Of The CyberKnife System Reinforce The Device's Broad-based Radiation Treatment Capabilities For Central Nervous System Tumors

Needham analyst Ryan MacDonald reiterates Yext (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) with a Buy and maintains $10 price target.

YEXT

Needham Reiterates Buy on Yext, Maintains $10 Price Target

The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">AMC Entertainment Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>)</h3>
<ul>
<li>The company on Monday announced a major expansion of Dolby Cinema at AMC theaters in the United States. "For a decade, AMC and Dolby have provided moviegoers with incredible premium experiences – making the biggest blockbusters even bigger, brighter, louder, and more immersive," said Adam Aron, chairman and CEO of AMC Entertainment. "The expansion of this partnership is a powerful demonstration of AMC's ongoing commitment to deliver this premium experience – sought out by filmmakers, studio partners, and our guests – to even more of our theaters and AMC moviegoers around the United States." The company's stock fell around 10% over the past month and has a 52-week low of $2.38.</li>
<li>RSI Value: 28.6</li>
<li>AMC Price Action: Shares of AMC fell 1.1% to close at $2.75 on Wednesday.</li>
<li>Edge Stock Ratings: 22.48 Momentum score with Value at 16.78.</li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/amc"><img loading="lazy" decoding="async" width="437" height="172" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041006/image-1-6.png" alt="" class="wp-image-854764" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041006/image-1-6.png 437w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041006/image-1-6-300x118.png 300w" sizes="(max-width: 437px) 100vw, 437px" /></a></figure>
<h3 class="wp-block-heading">Thryv Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRY#NASDAQ">THRY</a>)&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Feb. 27, Thryv Holdings posted upbeat quarterly results. &#8220;We delivered a strong fourth quarter with a robust increase in revenue and record SaaS margins, reaching a pivotal inflection point as SaaS now drives the majority of our revenue, reinforcing our transformation into a leading software company,&#8221; said Joe Walsh, Thryv Chairman and CEO. The company's stock fell around 20% over the past month and <a href="https://www.benzinga.com/quote/THRY">has a 52-week low</a> of $12.47.</li>
<li>RSI Value: 25.1</li>
<li>THRY Price Action: Shares of Thryv gained 0.9% to close at $13.11 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0403">THRY stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0403"><img loading="lazy" decoding="async" width="925" height="838" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041112/image-30.png" alt="" class="wp-image-854766" style="width:564px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041112/image-30.png 925w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041112/image-30-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041112/image-30-768x696.png 768w" sizes="(max-width: 925px) 100vw, 925px" /></a></figure>
<h3 class="wp-block-heading">Iridium Communications Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRDM#NASDAQ">IRDM</a>)</h3>
<ul>
<li>Iridium Communications will host a conference call on Tuesday, April 22, to discuss its first quarter results. The company's stock fell around 13% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/IRDM">low of $24.14</a>.</li>
<li>RSI Value: 28.4</li>
<li>IRDM Price Action: Shares of Iridium Communications fell 1.1% to close at $27.03 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0403">breakout in IRDM shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="900" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041204/image-31.png" alt="" class="wp-image-854767" style="width:539px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041204/image-31.png 900w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041204/image-31-300x279.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03041204/image-31-768x714.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
BZ Edge Rankings: Find out where other stocks stand—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">explore the full comparison now</a>. 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44604078/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

IRDM

THRY

Top 3 Tech And Telecom Stocks You'll Regret Missing This Month

Citigroup analyst Paul Lejuez upgrades BJ's Wholesale Club Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) from Neutral to Buy and raises the price target from $115 to $130.

Upgrades

Citigroup Upgrades BJ's Wholesale Club Hldgs to Buy, Raises Price Target to $130

HC Wainwright &amp; Co. analyst Robert Burns maintains TuHURA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HURA#NASDAQ">HURA</a>) with a Buy and lowers the price target from $13 to $12.

HURA

HC Wainwright & Co. Maintains Buy on TuHURA Biosciences, Lowers Price Target to $12

Citigroup analyst Steven Zaccone downgrades RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) from Buy to Neutral and lowers the price target from $437 to $200.

Comments

Chemours

Vendite allo scoperto

Chemours (NYSE:CC) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO